NanoLogix(Sharon, Pennsylvania), formerlyInfectech, reported that its stock symbol has changed from: OTC: IFEC to OTC: NNLX in accordance with its name change to NanoLogix.

NanoLogix is engaged in the research, development and commercialization of technologies for the production of bacteria- and disease-testing kits, alternative sources of fuel, cancer therapy and remediation of toxic materials.

The company’s portfolio includes 31 patents.